For the Inventor, By the Inventor

Enter assignee name

Newark, DE, United States of America

Ibio Limited

USPTO Granted Patents = 23

% Expired Patents = 26.1

CIPO Patents = 2

EPO Patents = 7

Trademarks = 6

Forward Citations = 46

Loading Chart...

Loading Chart...

49 inventors (with patents filed for the assignee):

Vidadi Yusibov (15 out of 30 patents)

Vadim Mett (9 out of 22 patents)

Shailaja Rabindran (5 out of 7 patents)

4. Oleg Fedorkin (4 out of 6 patents)

5. Konstantin Musiychuk (3 out of 7 patents)

6. Matthew Paul Greving (3 out of 8 patents)

7. Phung Tu Gip (3 out of 3 patents)

8. Mohan Srinivasan (2 out of 78 patents)

9. Jessica Chichester (2 out of 2 patents)

10. Lauren Goldschmidt (2 out of 2 patents)

11. Yoko Shoji (2 out of 2 patents)

12. Burt D Ensley (2 out of 18 patents)

13. Kevin Eduard Hauser (2 out of 2 patents)

14. Ramesh Baliga (1 out of 29 patents)

15. Angeles Estelles (1 out of 11 patents)

23 patents: Sort by Forward Citations

1. 12473368 - CD25 Antibodies (2025-11-18),

2. 12441803 - Engineered CD25 polypeptides and uses thereof (2025-10-14),

3. 12215163 - CD25 antibodies (2025-02-04),

4. 12129302 - Anti-CD-25 antibody (2024-10-29),

5. 11673926 - In vivo de-glycosylation of recombinant proteins by co-expression with PNGase F (2023-06-13),

6. 11545238 - Machine learning method for protein modelling to design engineered peptides (2023-01-03),

7. 10844392 - Materials and methods for producing endostatin fusion polypeptides in plant cells (2020-11-24),

8. 9809644 - Influenza hemagglutinin antibodies, compositions and related methods (2017-11-07),

9. 9765349 - System for expression of genes in plants (2017-09-19),

10. 9551001 - System for expression of genes in plants (2017-01-24),

11. 9115201 - Humanized neuraminidase antibody and methods of use thereof (2015-08-25),

12. 9012199 - Recombinant carrier molecule for expression, delivery and purification of target polypeptides (2015-04-21),

13. 8962278 - Compositions and methods for production of immunoglobulins (2015-02-24),

14. 8951791 - System for expression of genes in plants (2015-02-10),

15. 8945580 - [object Object] (2015-02-03),

Ibio Limited is a biotechnology company based in Newark, Delaware, specializing in the development of innovative plant-based biopharmaceuticals. The company focuses on leveraging its proprietary technology platform to produce therapeutic proteins and vaccines efficiently. With a commitment to advancing healthcare solutions, Ibio is engaged in research and development across various therapeutic areas, aiming to address unmet medical needs through its unique approach to biologics manufacturing.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

23 Patents

#15 in Newark, DE

#246 in Delaware

#14,401 in US

#27,619 in the World

Newark, DE, United States of America

Ibio Limited

Forward Citations = 46

49 inventors:

Vidadi Yusibov (15 out of 30 patents)

Vadim Mett (9 out of 22 patents)

Shailaja Rabindran (5 out of 7 patents)

4. Oleg Fedorkin (4 out of 6 patents)

5. Konstantin Musiychuk (3 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…